NAS:EUCRU (USA)
Units (1 Ord & 1/3 War)
$
10.02
(0%)
09:42 AM EST
What is a stock summary page? Click here for an overview.
Business Description
Eucrates Biomedical Acquisition Corp
NAICS : 551112
SIC : 6719
Share Class Description:
EUCRU: Units (1 Ord & 1/3 War)Description
Eucrates Biomedical Acquisition Corp is a blank check company.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 3.49 | |||||
| 12-1 Month Momentum % | 4.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.03 | |||||
| Quick Ratio | 2.03 | |||||
| Cash Ratio | 0.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | 2.94 | |||||
| ROA % | 2.79 | |||||
| ROIC % | -0.81 | |||||
| 3-Year ROIIC % | -0.05 | |||||
| ROC (Joel Greenblatt) % | -487.26 | |||||
| ROCE % | -0.81 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 49.46 | |||||
| PE Ratio without NRI | 49.46 | |||||
| PB Ratio | 4.95 | |||||
| EV-to-EBIT | -60.56 | |||||
| EV-to-EBITDA | -60.56 | |||||
| EV-to-FCF | -67.1 | |||||
| Earnings Yield (Greenblatt) % | -1.65 | |||||
| FCF Yield % | -1.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EUCRU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Eucrates Biomedical Acquisition Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 5.01 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.026436 | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | 4.64 | ||
| 52-Week Range ($) | 9.76 - 10.63 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eucrates Biomedical Acquisition Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eucrates Biomedical Acquisition Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eucrates Biomedical Acquisition Corp Frequently Asked Questions
What is Eucrates Biomedical Acquisition Corp(EUCRU)'s stock price today?
The current price of EUCRU is $10.02. The 52 week high of EUCRU is $10.63 and 52 week low is $9.76.
When is next earnings date of Eucrates Biomedical Acquisition Corp(EUCRU)?
The next earnings date of Eucrates Biomedical Acquisition Corp(EUCRU) is .
Does Eucrates Biomedical Acquisition Corp(EUCRU) pay dividends? If so, how much?
Eucrates Biomedical Acquisition Corp(EUCRU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers